156 related articles for article (PubMed ID: 11704172)
1. Efficacy and safety of a transdermal contraceptive system.
Smallwood GH; Meador ML; Lenihan JP; Shangold GA; Fisher AC; Creasy GW;
Obstet Gynecol; 2001 Nov; 98(5 Pt 1):799-805. PubMed ID: 11704172
[TBL] [Abstract][Full Text] [Related]
2. Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
Goa KL; Warner GT; Easthope SE
Treat Endocrinol; 2003; 2(3):191-206. PubMed ID: 15966567
[TBL] [Abstract][Full Text] [Related]
3. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
J Fam Plann Reprod Health Care; 2004 Jan; 30(1):43-5. PubMed ID: 15006313
[TBL] [Abstract][Full Text] [Related]
4. Transdermal contraception.
Creasy GW; Abrams LS; Fisher AC
Semin Reprod Med; 2001 Dec; 19(4):373-80. PubMed ID: 11727179
[TBL] [Abstract][Full Text] [Related]
5. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).
Sibai BM; Odlind V; Meador ML; Shangold GA; Fisher AC; Creasy GW
Fertil Steril; 2002 Feb; 77(2 Suppl 2):S19-26. PubMed ID: 11849632
[TBL] [Abstract][Full Text] [Related]
6. Transdermal contraception: evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study.
Dittrich R; Parker L; Rosen JB; Shangold G; Creasy GW; Fisher AC;
Am J Obstet Gynecol; 2002 Jan; 186(1):15-20. PubMed ID: 11810078
[TBL] [Abstract][Full Text] [Related]
7. A clinical study of transdermal contraceptive patch in Thai adolescence women.
Piyasirisilp R; Taneepanichskul S
J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
[TBL] [Abstract][Full Text] [Related]
8. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.
Archer DF; Bigrigg A; Smallwood GH; Shangold GA; Creasy GW; Fisher AC
Fertil Steril; 2002 Feb; 77(2 Suppl 2):S27-31. PubMed ID: 11849633
[TBL] [Abstract][Full Text] [Related]
9. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.
Zieman M; Guillebaud J; Weisberg E; Shangold GA; Fisher AC; Creasy GW
Fertil Steril; 2002 Feb; 77(2 Suppl 2):S13-8. PubMed ID: 11849631
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
Archer DF; Maheux R; DelConte A; O'Brien FB
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):39-44. PubMed ID: 10561674
[TBL] [Abstract][Full Text] [Related]
11. [Safety evaluation of a transdermal contraceptive system with an oral contraceptive].
Radowicki S; Skórzewska K; Szlendak K
Ginekol Pol; 2005 Nov; 76(11):884-9. PubMed ID: 16566363
[TBL] [Abstract][Full Text] [Related]
12. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
[TBL] [Abstract][Full Text] [Related]
13. Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study.
Weisberg F; Bouchard C; Moreau M; Audet MC; Mawdsley S; Dattani D; Dinniwell J; Horbay GL;
J Obstet Gynaecol Can; 2005 Apr; 27(4):350-9. PubMed ID: 15937609
[TBL] [Abstract][Full Text] [Related]
14. Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants.
Abrams LS; Skee DM; Natarajan J; Wong FA; Lasseter KC
Contraception; 2001 Nov; 64(5):287-94. PubMed ID: 11777488
[TBL] [Abstract][Full Text] [Related]
15. The transdermal contraceptive patch: a new approach to hormonal contraception.
Burkman RT
Int J Fertil Womens Med; 2002; 47(2):69-76. PubMed ID: 11991433
[TBL] [Abstract][Full Text] [Related]
16. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
17. Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial.
Kaunitz AM; Portman D; Westhoff CL; Archer DF; Mishell DR; Rubin A; Foegh M
Obstet Gynecol; 2014 Feb; 123(2 Pt 1):295-303. PubMed ID: 24402597
[TBL] [Abstract][Full Text] [Related]
18. A clinical study of transdermal contraceptive patch in Thai women.
Suwanmalee O; Taneepanichskul S
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S1-4. PubMed ID: 17726805
[TBL] [Abstract][Full Text] [Related]
19. Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study.
Wiegratz I; Bassol S; Weisberg E; Mellinger U; Merz M
Reprod Sci; 2014 Dec; 21(12):1518-25. PubMed ID: 24784719
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial.
Audet MC; Moreau M; Koltun WD; Waldbaum AS; Shangold G; Fisher AC; Creasy GW;
JAMA; 2001 May; 285(18):2347-54. PubMed ID: 11343482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
